Single-cell and bulk sequencing analyses reveal the immune suppressive role of PTPN6 in glioblastoma
暂无分享,去创建一个
Tao Wang | Shidi Zhao | Xiaonan Zhang | Jie Chen | Ming Zhang | Saisai Liu | Tianyu Wu | Baiqing Li | Hongtao Wang | Li Li | Chun Wang | Li Huang | Baiqing Li | Tao Wang
[1] Bin Bai,et al. Pan-cancer analyses of classical protein tyrosine phosphatases and phosphatase-targeted therapy in cancer , 2022, Frontiers in Immunology.
[2] Xiao Guo,et al. Immunogenomic Landscape in Breast Cancer Reveals Immunotherapeutically Relevant Gene Signatures , 2022, Frontiers in Immunology.
[3] H. Takematsu,et al. The Protein Tyrosine Phosphatase SHP-1 (PTPN6) but Not CD45 (PTPRC) Is Essential for the Ligand-Mediated Regulation of CD22 in BCR-Ligated B Cells , 2021, The Journal of Immunology.
[4] Zhen-ping Zhu,et al. Bispecific antibody simultaneously targeting PD1 and HER2 inhibits tumor growth via direct tumor cell killing in combination with PD1/PDL1 blockade and HER2 inhibition , 2021, Acta pharmacologica Sinica.
[5] F. Lieberman,et al. TIGIT and PD-1 Immune Checkpoint Pathways Are Associated With Patient Outcome and Anti-Tumor Immunity in Glioblastoma , 2021, Frontiers in Immunology.
[6] G. Hu,et al. BFAR coordinates TGFβ signaling to modulate Th9-mediated cancer immunotherapy , 2021, The Journal of experimental medicine.
[7] C. Langer,et al. Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint Inhibitor-Based Therapy in Patients With Advanced Non-Small-Cell Lung Cancer. , 2021, JAMA oncology.
[8] J. Larkin,et al. Predictive biomarkers for response to immune checkpoint inhibition. , 2021, Seminars in cancer biology.
[9] Xinying Zhang,et al. The role of Src homology region 2 domain-containing phosphatase-1 hypermethylation in the classification of patients with myelodysplastic syndromes and its association with signal transducer and activator of transcription 3 phosphorylation in skm-1 cells , 2021, The Journal of international medical research.
[10] P. Van Loo,et al. Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition , 2021, Cell.
[11] Wei-Qing Ma,et al. PTPN6 promotes chemosensitivity of colorectal cancer cells via inhibiting the SP1/MAPK signalling pathway , 2020, Cell biochemistry and function.
[12] S. Iborra,et al. SHP-1 Regulates Antigen Cross-Presentation and Is Exploited by Leishmania to Evade Immunity. , 2020, Cell reports.
[13] J. Barnholtz-Sloan,et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017. , 2020, Neuro-oncology.
[14] M. Goldsmith,et al. Shp1 Loss Enhances Macrophage Effector Function and Promotes Anti-Tumor Immunity , 2020, Frontiers in Immunology.
[15] Jing Wang,et al. Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers , 2020, Nature Communications.
[16] Haitao Niu,et al. The Analysis of PTPN6 for Bladder Cancer: An Exploratory Study Based on TCGA , 2020, Disease markers.
[17] Z. Wang,et al. Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data for Chinese Glioma Patients , 2020, bioRxiv.
[18] Mariella G. Filbin,et al. An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma , 2019, Cell.
[19] Shaowei Zhang,et al. Aberrant promoter 2 methylation‑mediated downregulation of protein tyrosine phosphatase, non‑receptor type 6, is associated with progression of esophageal squamous cell carcinoma. , 2019, Molecular medicine reports.
[20] G. Mills,et al. Characterization of hypoxia-associated molecular features to aid hypoxia-targeted therapy , 2019, Nature Metabolism.
[21] Wei Liu,et al. CancerSEA: a cancer single-cell state atlas , 2018, Nucleic Acids Res..
[22] G. Freeman,et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response , 2018, Nature Medicine.
[23] James A. Eddy,et al. The Immune Landscape of Cancer. , 2018, Immunity.
[24] Li Ding,et al. Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines. , 2018, Cell systems.
[25] R. Grossman,et al. Discovering novel pharmacogenomic biomarkers by imputing drug response in cancer patients from large genomics studies , 2017, Genome research.
[26] Altaf Ahmad,et al. Implication of protein tyrosine phosphatase SHP-1 in cancer-related signaling pathways. , 2016, Future oncology.
[27] Gianluca Bontempi,et al. TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data , 2015, Nucleic acids research.
[28] O. Gallego,et al. Nonsurgical treatment of recurrent glioblastoma. , 2015, Current oncology.
[29] F. Krötz,et al. The Tyrosine Phosphatase SHP-1 Regulates Hypoxia Inducible Factor-1α (HIF-1α) Protein Levels in Endothelial Cells under Hypoxia , 2015, PloS one.
[30] A. Zakrzewska,et al. Deficiency in Hematopoietic Phosphatase Ptpn6/Shp1 Hyperactivates the Innate Immune System and Impairs Control of Bacterial Infections in Zebrafish Embryos , 2013, The Journal of Immunology.
[31] Sridhar Ramaswamy,et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells , 2012, Nucleic Acids Res..
[32] S. Leenstra,et al. Recent advances in the molecular understanding of glioblastoma , 2012, Journal of Neuro-Oncology.
[33] Helga Thorvaldsdóttir,et al. Molecular signatures database (MSigDB) 3.0 , 2011, Bioinform..
[34] G. Getz,et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.
[35] Wanling Yang,et al. Linked region detection using high-density SNP genotype data via the minimum recombinant model of pedigree haplotype inference , 2009, BMC Bioinformatics.
[36] J. Mesirov,et al. From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005 .
[37] M. Daly,et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.
[38] Robert L Bowman,et al. GlioVis data portal for visualization and analysis of brain tumor expression datasets. , 2017, Neuro-oncology.